SecSonar.com

Humana Inc. (HUM)

Humana Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Humana Inc. (HUM) is a Medical - Healthcare Plans company based in US with a market capitalization of $36.8B. Revenue grew 10.1% year-over-year and the company generated $375M in free cash flow. This page tracks HUM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 65.68K employees · IPO Dec 31, 1981

Valuation

Valuation & price

$305.12 · as of May 17, 2026 · -25.5% vs 52w high

31.0

P/E ratio

Latest-FY diluted EPS

2.09

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$397$280$164Jul 25Dec 25Jul 26Jul 7, 25$237.21Jul 9, 25$236.70Jul 11, 25$230.67Jul 15, 25$221.90Jul 17, 25$223.55Jul 21, 25$223.43Jul 23, 25$237.12Jul 25, 25$237.98Jul 29, 25$232.62Jul 31, 25$249.87Aug 4, 25$247.35Aug 6, 25$256.62Aug 11, 25$266.67Aug 13, 25$281.99Aug 15, 25$286.39Aug 19, 25$288.25Aug 21, 25$294.47Aug 25, 25$297.20Aug 27, 25$297.26Aug 29, 25$303.66Sep 3, 25$311.98Sep 5, 25$307.92Sep 9, 25$273.02Sep 11, 25$278.72Sep 16, 25$272.32Sep 18, 25$264.86Sep 22, 25$257.87Sep 24, 25$261.97Sep 26, 25$254.95Sep 30, 25$260.17Oct 2, 25$256.62Oct 6, 25$295.20Oct 8, 25$298.04Oct 10, 25$280.22Oct 14, 25$261.61Oct 16, 25$267.28Oct 21, 25$295.20Oct 23, 25$291.30Oct 27, 25$292.34Oct 29, 25$292.67Oct 31, 25$278.19Nov 4, 25$281.87Nov 6, 25$251.11Nov 10, 25$238.42Nov 12, 25$240.48Nov 14, 25$237.12Nov 18, 25$234.10Nov 20, 25$223.29Nov 25, 25$237.88Nov 28, 25$245.77Dec 2, 25$241.96Dec 4, 25$253.02Dec 8, 25$256.39Dec 10, 25$256.66Dec 12, 25$268.45Dec 16, 25$258.16Dec 18, 25$260.67Dec 22, 25$257.68Dec 24, 25$259.25Dec 29, 25$258.34Jan 2, 26$264.48Jan 6, 26$279.84Jan 8, 26$277.57Jan 12, 26$276.59Jan 14, 26$274.14Jan 16, 26$273.28Jan 21, 26$270.67Jan 23, 26$266.50Jan 27, 26$207.93Jan 29, 26$196.67Feb 2, 26$187.20Feb 4, 26$192.07Feb 9, 26$189.49Feb 11, 26$175.40Feb 13, 26$184.10Feb 18, 26$187.12Feb 20, 26$189.83Feb 24, 26$174.64Feb 26, 26$186.83Mar 2, 26$187.28Mar 4, 26$183.11Mar 6, 26$179.15Mar 10, 26$173.62Mar 12, 26$163.67Mar 17, 26$170.77Mar 19, 26$166.45Mar 23, 26$170.14Mar 25, 26$174.24Mar 27, 26$169.09Mar 31, 26$173.39Apr 2, 26$177.83Apr 7, 26$197.15Apr 9, 26$197.32Apr 13, 26$198.23Apr 15, 26$198.37Apr 17, 26$205.14Apr 22, 26$217.40Apr 24, 26$215.23Apr 28, 26$229.72Apr 30, 26$236.44May 4, 26$237.96May 6, 26$246.33May 8, 26$274.96May 12, 26$295.35May 14, 26$301.35May 18, 26$306.00May 20, 26$304.10May 22, 26$307.95May 28, 26$308.70Jun 1, 26$328.31Jun 3, 26$327.54Jun 5, 26$350.08Jun 9, 26$363.18Jun 11, 26$368.69Jun 15, 26$380.26Jun 17, 26$362.00Jun 22, 26$360.72Jun 24, 26$361.64Jun 26, 26$383.84Jul 2, 26$396.75
$163.6752-week range$409.42
Loading valuation history…

Fundamentals

Key fundamentals

$36.8B

Market cap

10.1%

Revenue growth (YoY)

14.5%

Gross margin

$375M

Free cash flow (USD)

$8.7B

Net debt

-0.1%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$54.4BFY 2017$53.8BFY 2018$56.9BFY 2019$64.9BFY 2020$77.2BFY 2021$83.6BFY 2022$92.9BFY 2023$106.4BFY 2024$117.8BFY 2025$129.7B
$54.4B$129.7B

Free cash flow by year

2016 → 2025

FY 2016$1.4BFY 2017$3.5BFY 2018$1.6BFY 2019$4.5BFY 2020$4.7BFY 2021$920.0MFY 2022$3.5BFY 2023$3.0BFY 2024$2.4BFY 2025$375.0M
$1.4B$375M

Gross margin by year

2021 → 2025

FY 202117.3%FY 202218.5%FY 202316.9%FY 202414.6%FY 202514.5%
17.3%14.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 29, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEarnings Guidance ReaffirmedJun 1, 2026Filing
  • 8-K eventTrust Declaration AmendedMay 19, 2026Filing
  • 8-K eventEarnings ReleaseApr 29, 2026Filing
  • Quarterly report10-Q FiledApr 29, 2026Filing
  • 8-K eventAnnual Meeting ResultsApr 20, 2026Filing
  • 8-K eventDirector AppointmentApr 10, 2026Filing

Questions

Frequently asked questions

What is Humana Inc.'s market cap?

Humana Inc. (HUM) has a market capitalization of $36.8B.

What is HUM's P/E ratio?

HUM trades at a price-to-earnings ratio of 31.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is HUM's price-to-book (P/B) ratio?

HUM trades at 2.09 times book value per share.

Are insiders buying HUM stock?

SEC Form 4 filings show no open-market insider buys at Humana Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Healthcare Plans

CNC

Centene Corporation

$29.2B

MOH

Molina Healthcare, Inc.

$9.1B

OSCR

Oscar Health, Inc.

$5.8B

ALHC

Alignment Healthcare, Inc.

$3.2B

CLOV

Clover Health Investments, Corp.

$2.1B

CI

Cigna Corporation

$73.7B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.